DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
This Office action is responsive to an amendment filed August 29, 2025. Claims 2-21 are pending. New claims 2-21 have been added. Claim 1 has been canceled.
Information Disclosure Statement
The information disclosure statement (IDS) submitted on November 10, 2025 is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claim(s) 2-5, 14-16, 19 & 21 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Rem-Bronneberg et al. (US 2018/0264291) (“Rem-Bronneberg” hereinafter).
In regards to claim 2, Rem-Bronneberg discloses a system for ultrasound treatment (i.e., ablation or hyperthermia, see abstract), comprising:
an applicator 14 including a plurality of ultrasound transducers 8, each ultrasound transducer 8 having at least one ultrasound element configured to vibrate under excitation to produce ultrasound waves, wherein the plurality of ultrasound transducers 8 are interconnected side-by-side in series in a chain with spaces defined between adjacent ultrasound transducers 8, the spaces enabling the applicator 14 to be flexed in accordance with a contour of a non-flat tissue surface of an epidermis layer (see at least abstract, figs. 1a-b & 9a and par 0039-0040 & 0060);
PNG
media_image1.png
502
686
media_image1.png
Greyscale
electrical circuitry 18 configured to excite ultrasound elements associated with the plurality of ultrasound transducers 8 to generate the ultrasound waves for heating target tissue beneath the epidermis layer (see at least abstract, figs. 6 & 7a and par 0008-0009, 0016, 0020, 0039-0040, 0043, 0052 & 0060-0063); and
a coolant source 25 connected to the applicator 14 in a manner enabling coolant to flow between the plurality of ultrasound transducers 8 in series while the applicator 14 is shaped in accordance with the contour of the non-flat tissue surface, to thereby cool the epidermis layer during heating of the target tissue beneath the epidermis layer (see at least fig. 1b and par 0040 & 0060).
In regards to claim 3, Rem-Bronneberg discloses the system of claim 2, further including a pump configured for circulating the coolant from the coolant source 25 to the plurality of ultrasound transducers 8 (see at least fig. 1b and par 0040 & 0060).
In regards to claim 4, Rem-Bronneberg discloses the system of claim 3, wherein the electrical circuitry 18 includes at least one processor configured to control the pump to maintain a temperature at the epidermis layer associated with the target tissue in a range of 50C to 400C (see at least fig. 7a and par 0054 & 0056).
In regards to claim 5, Rem-Bronneberg discloses the system of claim 2, wherein the electrical circuitry 18 includes at least one processor configured to cause ultrasound energy to be emitted at a frequency in a range of 9 MHz and 22 MHz (such as 9 or 10 MHz) (see at least par 0012, 0051 & 0060).
In regards to claim 14, Rem-Bronneberg discloses the system of claim 2, further including a plurality of flexible portions (of support 9) interconnecting the plurality of ultrasound transducers 8 (see at least fig. 1a and par 0040).
In regards to claim 15, Rem-Bronneberg discloses the system of claim 14, wherein each of the plurality of flexible portions (of support 9) is part of a common layer 9 of flexible material (see at least fig. 1a and par 0040).
In regards to claim 16, Rem-Bronneberg discloses a method for ultrasound treatment (i.e., ablation or hyperthermia, see abstract), the method comprising:
placing an applicator 14 on a non-flat tissue surface of epidermis, the applicator 14 including a plurality of ultrasound transducers 8 connected in series in a manner permitting the applicator 14 to flex in accordance with a contour of the non-flat tissue surface, and wherein each ultrasound transducer 8 is configured to vibrate under excitation to produce ultrasound waves (see at least abstract, figs. 1a-b & 9a and par 0039-0040 & 0060);
PNG
media_image1.png
502
686
media_image1.png
Greyscale
exciting the ultrasound transducers 8 to generate the ultrasound waves for heating target tissue beneath the epidermis layer (see at least abstract, fig. 6 and par 0008-0009, 0016, 0020, 0039-0040, 0043, 0052 & 0060-0063); and
cooling the epidermis layer during heating of the target tissue beneath the epidermis layer using a coolant source 25 connected to the applicator 14 in a manner enabling coolant to flow between the plurality of ultrasound transducers 8 in series while the applicator 14 is shaped in accordance with the contour of the non-flat tissue surface (see at least fig. 1b and par 0040 & 0060).
In regards to claim 19, Rem-Bronneberg discloses the method of claim 16, wherein exciting the ultrasound transducers 8 includes exciting a first transducer 8 to produce a first thermal effect at a first depth and exciting a second transducer 8 to produce a second thermal effect different from the first thermal effect at a second depth, different from the first depth (see at least par 0039).
In regards to claim 21, Rem-Bronneberg discloses a non-transitory computer readable medium containing instructions that when executed by at least one processor cause the at least one processor to perform operations for ultrasound treatment (i.e., ablation or hyperthermia, see abstract), the operations comprising:
activating an applicator 14 including a plurality of ultrasound transducers 8, each ultrasound transducer 8 having at least one ultrasound element 8 configured to vibrate under excitation to produce ultrasound waves, wherein the plurality of ultrasound transducers 8 are interconnected side-by-side in series in a chain with spaces defined between adjacent ultrasound transducers 8, the spaces enabling the applicator 14 to be flexed in accordance with a contour of a non-flat tissue surface of an epidermis layer (see at least abstract, figs. 1a-b & 9a and par 0039-0040 & 0060);
PNG
media_image1.png
502
686
media_image1.png
Greyscale
exciting ultrasound elements associated with the plurality of ultrasound transducers 8 as the applicator 14 is shaped in accordance with the contour of the non-flat tissue, to generate the ultrasound waves for heating target tissue beneath the epidermis layer (see at least abstract, figs. 6 & 7a and par 0008-0009, 0016, 0020, 0039-0040, 0043, 0052 & 0060-0063); and
cooling the epidermis layer during heating of the target tissue beneath the epidermis layer using a coolant source 25 connected to the applicator 14 in a manner enabling coolant to flow between the plurality of ultrasound transducers 8 in series while the applicator 14 is shaped in accordance with the contour of the non-flat tissue surface (see at least fig. 1b and par 0040 & 0060).
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
Claim(s) 2-21 is/are rejected under 35 U.S.C. 103 as being unpatentable over Barthe et al. (US 2012/0271294) (“Barthe” hereinafter) in view of Cornejo et al. (WO 99/48621) (“Cornejo” hereinafter).
In regards to claim 2, Barthe discloses a system for ultrasound treatment (see at least par 0022, 0041, 0091, 0250, 0253-254 & 0260), comprising:
an applicator including a plurality of ultrasound transducers (19, 119, 219, 2404, 3104), each ultrasound transducer (19, 119, 219, 2404, 3104) having at least one ultrasound element (19, 119, 219, 2404, 3104) configured to vibrate under excitation to produce ultrasound waves (see at least fig. 31 and par 0123, 0250 & 0290-0292),
PNG
media_image2.png
484
654
media_image2.png
Greyscale
electrical circuitry (20, 86) configured to excite ultrasound elements (19, 119, 219, 2404, 3104) associated with the plurality of ultrasound transducers (19, 119, 219, 2404, 3104) to generate the ultrasound waves for heating target tissue beneath the epidermis layer (see at least figs. 5 & 7 and par 0136, 0188, 0241, 0260 & 0282); and
a coolant source (i.e., acoustic coupling and cooling system) connected to the applicator in a manner enabling coolant to flow between the plurality of ultrasound transducers (19, 119, 219, 2404, 3104) in series while the applicator is shaped in accordance with the contour of the non-flat tissue surface (see fig. 2), to thereby cool the epidermis layer during heating of the target tissue beneath the epidermis layer (see at least figs. 5 & 14 and par 0129, 0135, 0181, 0187, 0234, 0240, 0275, 0281, 0286-0287 & 0309).
Barthe discloses a system, as described above, that fails to explicitly teach a system wherein the plurality of ultrasound transducers are interconnected side-by-side in series in a chain with spaces defined between adjacent ultrasound transducers, the spaces enabling the applicator to be flexed in accordance with a contour of a non-flat tissue surface of an epidermis layer.
However, Cornejo teaches that it is known to provide a system wherein the plurality of ultrasound transducers (15, 32) are interconnected side-by-side in series in a chain with spaces defined between adjacent ultrasound transducers (15, 32) (see fig. 2B),
PNG
media_image3.png
420
712
media_image3.png
Greyscale
the spaces enabling the applicator to be flexed in accordance with a contour of a non-flat tissue surface of an epidermis layer (see at least abstract, figs. 1A-C, 2A-B, 3A-C & 4 and pg. 2, lines 13-16; pg. 3, lines 12-15; pg. 6, lines 2-11).
Therefore, it would have been obvious to one of ordinary skill in the art at the time Applicant’s invention was filed to provide the system of Barthe wherein the plurality of ultrasound transducers are interconnected side-by-side in series in a chain with spaces defined between adjacent ultrasound transducers, the spaces enabling the applicator to be flexed in accordance with a contour of a non-flat tissue surface of an epidermis layer as taught by Cornejo since such a modification would amount to applying a known technique (i.e., as taught by Cornejo) to a known device (i.e., as taught by Barthe) ready for improvement to achieve a predictable result such as providing an ultrasound array that can permit acoustic energy generated by the transducers to be efficiently applied and coupled to the contours of the human anatomy for therapeutic applications (see pg. 4, lines 21-25 of Cornejo)--See KSR, 550 U.S. at___, 82 USPQ2d at 1396 (See MPEP § 214 3 for a discussion of the rationale(s) listed above. See also MPEP § 2144 - §2144.09 for additional guidance regarding support for obviousness determinations).
In regards to claim 3, Barthe discloses the system of claim 2, further including a pump configured for circulating the coolant from the coolant source (i.e., acoustic coupling and cooling system) to the plurality of ultrasound transducers (19, 119, 219, 2404, 3104) (see at least par 0287).
In regards to claim 4, Barthe discloses the system of claim 3, wherein the electrical circuitry (20, 86) includes at least one processor (see at least fig. 3 and par 0136, 0188, 0241, 0260 & 0282) configured to control the pump to maintain a temperature at the epidermis layer associated with the target tissue in a range of 50C to 400C (see at least par 0109, 0162 & 0209).
In regards to claim 5, Barthe discloses the system of claim 2, wherein the electrical circuitry (20, 86) includes at least one processor (see at least fig. 3 and par 0136, 0188, 0241, 0260 & 0282) configured to cause ultrasound energy to be emitted at a frequency in a range of 9 MHz and 22 MHz (see at least par 0042, 0046, 0119-0120 & 0173-0174).
In regards to claim 6, Barthe discloses the system of claim 5, wherein the processor (see at least fig. 3 and par 0136, 0188, 0241, 0260 & 0282) is further configured to cause a temperature to rise to a value between 500C and 800C in the target tissue (see at least par 0203, 0217 & 0262-0263) at a depth of between 0.5 mm and 5 mm from the epidermis layer (see at least par 0041-0042 & 0250).
In regards to claim 7, Barthe discloses the system of claim 2, wherein the coolant is an antifreeze fluid (i.e., refrigerant) (see at least par 0287).
In regards to claim 8, Barthe discloses the system of claim 2, further including one or more temperature sensors (i.e., thermal sensor) configured to measure a temperature associated with the epidermis layer (see at least par 0134, 0137, 0186, 0189, 0242, 0268, 0280 & 0286-0288).
In regards to claim 9, Barthe discloses the system of claim 8, wherein the electrical circuitry (20, 86) includes at least one processor (see at least fig. 3 and par 0136, 0188, 0241, 0260 & 0282) configured to control cooling of the epidermis layer based on temperature feedback from the one or more temperature sensors (i.e., thermal sensor) (see at least par 0137, 0189, 0242, 0268, 0286, 0280 & 0288).
In regards to claim 10, Barthe discloses the system of claim 2, wherein the electrical circuitry (20, 86) includes at least one processor (see at least fig. 3 and par 0136, 0188, 0241, 0260 & 0282) configured to initiate cooling of the epidermis layer before heating of the target tissue (i.e., when operating in a closed loop feedback arrangement) (see at least figs. 8A-B and par 0129, 0135, 0181, 0187, 0234, 0240, 0275, 0281, 0286-0287 & 0309).
In regards to claim 11, Barthe discloses the system of claim 2, wherein the electrical circuitry (20, 86) includes at least one processor (see at least fig. 3 and par 0136, 0188, 0241, 0260 & 0282) configured to initiate cooling of the epidermis layer after heating of the target tissue (i.e., when operating in a closed loop feedback arrangement) (see at least figs. 8A-B and par 0129, 0135, 0181, 0187, 0234, 0240, 0275, 0281, 0286-0287 & 0309).
In regards to claim 12, while Barthe discloses the system of claim 2, wherein the electrical circuitry (20, 86) includes at least one processor (see at least fig. 3 and par 0136, 0188, 0241, 0260 & 0282) configured to initiate cooling of the epidermis layer (see at least figs. 8A-B and par 0129, 0135, 0181, 0187, 0234, 0240, 0275, 0281, 0286-0287 & 0309), Barthe as modified by Cornejo discloses the system of claim 2, that fails to explicitly teach a system wherein the electrical circuitry thereof includes at least one processor thereof configured to initiate cooling of the epidermis layer concurrently with heating of the target tissue. However, it would have been obvious to one of ordinary skill in the art at the time Applicant’s invention was filed to provide the system of wherein the electrical circuitry thereof includes at least one processor, as taught by Barthe as modified by Cornejo configured to initiate cooling of the epidermis layer concurrently with heating of the target tissue as claimed in order to carefully balance the intensity of delivered energy to ensure that the desired target regions are sufficiently heated while surrounding areas of the tissue such as the superficial tissue interface and/or deeper into tissue are not damaged (see at least par 0286-0287 of Barthe).
In regards to claim 13, Barthe discloses the system of claim 2, further including at least one of an active cooling element or a passive cooling element for cooling the coolant (see at least par 0287).
In regards to claim 14, Barthe discloses the system of claim 2, that fails to explicitly teach a system further including a plurality of flexible portions interconnecting the plurality of ultrasound transducers. However, Cornejo teaches that it is known to provide a system further including a plurality of flexible portions (i.e., fiber sheet 25) interconnecting the plurality of ultrasound transducers (15, 32) (see at least 1A-C, 2A-B, 3A-C & 4 and pg. 2, lines 13-16; pg. 3, lines 12-15; pg. 6, lines 2-11). Therefore, it would have been obvious to one of ordinary skill in the art at the time Applicant’s invention was filed to provide the system of Barthe further including a plurality of flexible portions interconnecting the plurality of ultrasound transducers as taught by Cornejo since such a modification would amount to applying a known technique (i.e., as taught by Cornejo) to a known device (i.e., as taught by Barthe) ready for improvement to achieve a predictable result such as providing an ultrasound array that can permit acoustic energy generated by the transducers to be efficiently applied and coupled to the contours of the human anatomy for therapeutic applications (see pg. 4, lines 21-25 of Cornejo)--See KSR, 550 U.S. at___, 82 USPQ2d at 1396 (See MPEP § 214 3 for a discussion of the rationale(s) listed above. See also MPEP § 2144 - §2144.09 for additional guidance regarding support for obviousness determinations).
In regards to claim 15, Barthe discloses the system of claim 14, that fails to explicitly teach a system wherein each of the plurality of flexible portions is part of a common layer of flexible material. However, Cornejo teaches that it is known to provide a system wherein each of the plurality of flexible portions is part of a common layer 25 of flexible material (see at least fig. 2B). Therefore, it would have been obvious to one of ordinary skill in the art at the time Applicant’s invention was filed to provide the system of Barthe wherein each of the plurality of flexible portions is part of a common layer of the flexible material as taught by Cornejo since such a modification would amount to applying a known technique (i.e., as taught by Cornejo) to a known device (i.e., as taught by Barthe) ready for improvement to achieve a predictable result such as providing an ultrasound array that can permit acoustic energy generated by the transducers to be efficiently applied and coupled to the contours of the human anatomy for therapeutic applications (see pg. 4, lines 21-25 of Cornejo)--See KSR, 550 U.S. at___, 82 USPQ2d at 1396 (See MPEP § 214 3 for a discussion of the rationale(s) listed above. See also MPEP § 2144 - §2144.09 for additional guidance regarding support for obviousness determinations).
In regards to claim 16, Barthe discloses a method for ultrasound treatment (see at least par 0022, 0041, 0091, 0250, 0253-254 & 0260), the method comprising:
placing an applicator on a non-flat tissue surface of epidermis, the applicator including a plurality of ultrasound transducers (19, 119, 219, 2404, 3104), and wherein each ultrasound transducer (19, 119, 219, 2404, 3104) is configured to vibrate under excitation to produce ultrasound waves (see at least fig. 31 and par 0123, 0250 & 0290-0292);
exciting the ultrasound transducers (19, 119, 219, 2404, 3104) to generate the ultrasound waves for heating target tissue beneath the epidermis layer (see at least figs. 5 & 7 and par 0136, 0188, 0241, 0260 & 0282); and
cooling the epidermis layer during heating of the target tissue beneath the epidermis layer using a coolant source (i.e., acoustic coupling and cooling system) connected to the applicator in a manner enabling coolant to flow between the plurality of ultrasound transducers (19, 119, 219, 2404, 3104) in series (see at least figs. 5 & 14 and par 0129, 0135, 0181, 0187, 0234, 0240, 0275, 0281, 0286-0287 & 0309).
Barthe discloses a method, as described above, that fails to explicitly teach a method with the applicator including a plurality of ultrasound transducers connected in series in a manner permitting the applicator to flex in accordance with a contour of the non-flat tissue surface, and wherein each ultrasound transducer is configured to vibrate under excitation to produce ultrasound waves while the applicator is shaped in accordance with the contour of the non-flat tissue surface.
However, Cornejo teaches that it is known to provide a method with the applicator including a plurality of ultrasound transducers (15, 32) connected in series in a manner permitting the applicator to flex in accordance with a contour of the non-flat tissue surface, and wherein each ultrasound transducer (15, 32) is configured to vibrate under excitation to produce ultrasound waves while the applicator is shaped in accordance with the contour of the non-flat tissue surface (see at least abstract, figs. 1A-C, 2A-B, 3A-C & 4 and pg. 2, lines 13-16; pg. 3, lines 12-15; pg. 6, lines 2-11).
Therefore, it would have been obvious to one of ordinary skill in the art at the time Applicant’s invention was filed to provide the method of Barthe with the applicator including a plurality of ultrasound transducers connected in series in a manner permitting the applicator to flex in accordance with a contour of the non-flat tissue surface, and wherein each ultrasound transducer is configured to vibrate under excitation to produce ultrasound waves while the applicator is shaped in accordance with the contour of the non-flat tissue surface as taught by Cornejo since such a modification would amount to applying a known technique (i.e., as taught by Cornejo) to a known device (i.e., as taught by Barthe) ready for improvement to achieve a predictable result such as providing an ultrasound array that can permit acoustic energy generated by the transducers to be efficiently applied and coupled to the contours of the human anatomy for therapeutic applications (see pg. 4, lines 21-25 of Cornejo)--See KSR, 550 U.S. at___, 82 USPQ2d at 1396 (See MPEP § 214 3 for a discussion of the rationale(s) listed above. See also MPEP § 2144 - §2144.09 for additional guidance regarding support for obviousness determinations).
In regards to claim 17, Barthe as modified by Cornejo discloses the method of claim 16, that fails to explicitly teach a method wherein cooling the epidermis layer is accomplished at a rate of between 1 K/min and 60 K/min. Barthe discloses (see at least figs. 8A-B and par 0286-0287 & 0309) that the cooling rate or flow needs to be optimized to control cooling of an interface surface or region between transducer probe and a region of interest and beyond and as such the cooling rate or flow of the device is disclosed to be a result effective variable in that it helps control cooling of an interface surface or region between transducer probe and a region of interest and beyond, thereby carefully balancing the intensity of delivered energy to ensure that the desired target regions are sufficiently heated while surrounding areas of the tissue such as the superficial tissue interface and/or deeper into tissue are not damaged. Therefore, it would have been obvious to one having ordinary skill in the art at the time of the invention to modify the method of Barthe as modified by Cornejo by cooling the epidermis layer at a rate of between 1 K/min and 60 K/min as a matter of routine optimization since it has been held that “where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation." In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955).
In regards to claim 18, Barthe discloses the method of claim 16, wherein exciting the transducers (19, 119, 219, 2404, 3104) includes concurrently operating at least two of the plurality of ultrasound transducers (19, 119, 219, 2404, 3104) at different frequencies to collectively emit unfocused ultrasound energy (see at least par 0120, 0149, 0174, 0200, 0225, 0255 & 0293).
In regards to claim 19, Barthe discloses the method of claim 16, wherein exciting the ultrasound transducers (19, 119, 219, 2404, 3104) includes exciting a first transducer to produce a first thermal effect at a first depth and exciting a second transducer to produce a second thermal effect different from the first thermal effect at a second depth, different from the first depth (see at least par 0101, 0103, 0116, 0140, 0148, 0152, 0164, 0170, 0192, 0199-0200 & 0250-0253).
In regards to claim 20, Barthe discloses the method of claim 16, wherein each of the plurality of ultrasound transducers (19, 119, 219, 2404, 3104) include at least one ultrasound element (19, 119, 219, 2404, 3104) and wherein the method further comprises exciting a first set of the ultrasound elements (19, 119, 219, 2404, 3104) at frequencies in a range of 300 kHz and 1 MHz (see at least par 0042 & 0119, 0173, 0224 & 0291), while a second set of ultrasound elements (19, 119, 219, 2404, 3104) is excited at frequencies in a range of 10 MHz and 20 MHz (see at least par 0042 & 0119, 0173, 0224 & 0291).
In regards to claim 21, Barthe discloses a non-transitory computer readable medium containing instructions that when executed by at least one processor (see at least fig. 3 and par 0136, 0188, 0241, 0260 & 0282) cause the at least one processor (see at least fig. 3 and par 0136, 0188, 0241, 0260 & 0282) to perform operations for ultrasound treatment (see at least par 0022, 0041, 0091, 0250, 0253-254 & 0260), the operations comprising:
activating an applicator including a plurality of ultrasound transducers (19, 119, 219, 2404, 3104), each ultrasound transducer (19, 119, 219, 2404, 3104) having at least one ultrasound element (19, 119, 219, 2404, 3104) configured to vibrate under excitation to produce ultrasound waves (see at least fig. 31 and par 0123, 0250 & 0290-0292);
exciting ultrasound elements (19, 119, 219, 2404, 3104) associated with the plurality of ultrasound transducers (19, 119, 219, 2404, 3104) as the applicator is shaped in accordance with the contour of the non-flat tissue, to generate the ultrasound waves for heating target tissue beneath the epidermis layer (see at least figs. 5 & 7 and par 0136, 0188, 0241, 0260 & 0282); and
cooling the epidermis layer during heating of the target tissue beneath the epidermis layer using a coolant source (i.e., acoustic coupling and cooling system) connected to the applicator in a manner enabling coolant to flow between the plurality of ultrasound transducers (19, 119, 219, 2404, 3104) in series (see at least figs. 5 & 14 and par 0129, 0135, 0181, 0187, 0234, 0240, 0275, 0281, 0286-0287 & 0309).
Barthe discloses a non-transitory computer readable medium containing instructions that when executed by at least one processor fail to cause the at least one processor to perform operations for ultrasound treatment wherein the plurality of ultrasound transducers are interconnected side-by-side in series in a chain with spaces defined between adjacent ultrasound transducers, the spaces enabling the applicator to be flexed in accordance with a contour of a non-flat tissue surface of an epidermis layer while the applicator is shaped in accordance with the contour of the non-flat tissue surface.
However, Cornejo teaches that it is known to provide device for ultrasound treatment wherein the plurality of ultrasound transducers (15, 32) are interconnected side-by-side in series in a chain with spaces defined between adjacent ultrasound transducers (15, 32) (see fig. 2B), the spaces enabling the applicator to be flexed in accordance with a contour of a non-flat tissue surface of an epidermis layer while the applicator is shaped in accordance with the contour of the non-flat tissue surface (see at least abstract, figs. 1A-C, 2A-B, 3A-C & 4 and pg. 2, lines 13-16; pg. 3, lines 12-15; pg. 6, lines 2-11).
Therefore, it would have been obvious to one of ordinary skill in the art at the time Applicant’s invention was filed to provide the non-transitory computer readable medium containing instructions that when executed by at least one processor cause the at least one processor of Barthe to perform operations for ultrasound treatment wherein the plurality of ultrasound transducers are interconnected side-by-side in series in a chain with spaces defined between adjacent ultrasound transducers, the spaces enabling the applicator to be flexed in accordance with a contour of a non-flat tissue surface of an epidermis layer while the applicator is shaped in accordance with the contour of the non-flat tissue surface as taught by Cornejo since such a modification would amount to applying a known technique (i.e., as taught by Cornejo) to a known device (i.e., as taught by Barthe) ready for improvement to achieve a predictable result such as providing an ultrasound array that can permit acoustic energy generated by the transducers to be efficiently applied and coupled to the contours of the human anatomy for therapeutic applications (see pg. 4, lines 21-25 of Cornejo)--See KSR, 550 U.S. at___, 82 USPQ2d at 1396 (See MPEP § 214 3 for a discussion of the rationale(s) listed above. See also MPEP § 2144 - §2144.09 for additional guidance regarding support for obviousness determinations).
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to RENE T TOWA whose telephone number is (313)446-6655. The examiner can normally be reached Mon-Fri, 9:00 AM-5:00 PM.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jason M. Sims can be reached at 571-272-7540. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/RENE T TOWA/Primary Examiner, Art Unit 3791